Nov. 9 at 2:37 PM
$ARQ $ITRM $TOYO $UPXI
ARQ: Recent soft earnings has left an opportunity to get in on a solid company at discounted prices. This one is a mid to long-term hold, and there is a lot of upside. Look for
$10+ in the next 12 months. Current price
$3.85.
ITRM: Likely one of the most massively undervalued biopharm plays on the market. Mcap sitting at sub
$30M with valuations exceeding
$500M. They have FDA approval on the world’s only oral penem antibiotic, and EC scheduled for 11/14. I’m expecting big news +/- buy out with target price
$5-7. Current price
$0.60. Basement is in. Uptrend has started. Get in while you can.
TOYO: This is another mid to long-term hold. Really solid company. Really solid set of books. Current price hovering at seven dollars a share. Expect 10+ in the next 3-6 months. 
UPXI: I love a heavily shorted play, and this one definitely counts. It is likely at/near basement levels, and I am looking closely at expanding a position. Solid C-suite with massive upside potential. Currently trading
$3.50’s. Look for >
$20 share in the next year.
